Cubist Systematic Strategies, LLC Milestone Pharmaceuticals Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$2.85 - $4.4 $11,505 - $17,762
4,037 Added 45.26%
12,957 $36,000
Q1 2023

May 15, 2023
SELL
$3.14 - $4.2 $257,398 - $344,290
-81,974 Reduced 90.19%
8,920 $35,000
Q4 2022

Feb 14, 2023
BUY
$3.53 - $9.5 $279,907 - $753,293
79,294 Added 683.57%
90,894 $359,000
Q3 2022

Nov 14, 2022
BUY
$5.86 - $9.43 $67,976 - $109,388
11,600 New
11,600 $107,000

Others Institutions Holding MIST

# of Institutions
45
Shares Held
28.6M
Call Options Held
200
Put Options Held
0
View Full List

About Milestone Pharmaceuticals Inc.

MIST Quotes by TradingView
  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $59.4M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email